Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2017 How Should Clinicians Weigh the Benefits and Harms of Discussing Politicized Topics that Influence Their Individual Patients’ Health? Diana Alame, MD, MBE and Robert D. Truog, MD The adverse health effects of climate change should be the focus of physician advocacy efforts and of conversations between physicians and their patients. AMA J Ethics. 2017;19(12):1174-1182. doi: 10.1001/journalofethics.2017.19.12.ecas3-1712. Medical Education Oct 2017 Lessons for Physicians from Flint’s Water Crisis Laura A. Carravallah, MD, Lawrence A. Reynolds, MD, and Susan J. Woolford, MD, MPH Physicians with interprofessional networks and environmental health training can better respond to public health crises. AMA J Ethics. 2017;19(10):1001-1010. doi: 10.1001/journalofethics.2017.19.10.medu1-1710. Policy Forum Dec 2014 Telemedicine: Innovation Has Outpaced Policy Karen Rheuban, MD, Christine Shanahan, and Katherine Willson For telemedicine to be properly integrated into everyday care in the twenty-first century, we need to advance beyond twentieth-century policy. Virtual Mentor. 2014;16(12):1002-1009. doi: 10.1001/virtualmentor.2014.16.12.pfor1-1412. Policy Forum Sep 2017 Compassionate Release Policy Reform: Physicians as Advocates for Human Dignity Andreas Mitchell and Brie Williams, MD, MS Compassionate release policies offering early release or parole to seriously ill incarcerated patients are underutilized and should be advocated for. AMA J Ethics. 2017;19(9):854-861. doi: 10.1001/journalofethics.2017.19.9.peer2-1709. Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708. Case and Commentary Jan 2005 Physician Activism: Doctors Go on Strike Karine Morin, LLM Virtual Mentor. 2005;7(1):121-124. doi: 10.1001/virtualmentor.2005.7.1.ccas21-0501. Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611. Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Dec 2017 How Should Clinicians Weigh the Benefits and Harms of Discussing Politicized Topics that Influence Their Individual Patients’ Health? Diana Alame, MD, MBE and Robert D. Truog, MD The adverse health effects of climate change should be the focus of physician advocacy efforts and of conversations between physicians and their patients. AMA J Ethics. 2017;19(12):1174-1182. doi: 10.1001/journalofethics.2017.19.12.ecas3-1712.
Medical Education Oct 2017 Lessons for Physicians from Flint’s Water Crisis Laura A. Carravallah, MD, Lawrence A. Reynolds, MD, and Susan J. Woolford, MD, MPH Physicians with interprofessional networks and environmental health training can better respond to public health crises. AMA J Ethics. 2017;19(10):1001-1010. doi: 10.1001/journalofethics.2017.19.10.medu1-1710.
Policy Forum Dec 2014 Telemedicine: Innovation Has Outpaced Policy Karen Rheuban, MD, Christine Shanahan, and Katherine Willson For telemedicine to be properly integrated into everyday care in the twenty-first century, we need to advance beyond twentieth-century policy. Virtual Mentor. 2014;16(12):1002-1009. doi: 10.1001/virtualmentor.2014.16.12.pfor1-1412.
Policy Forum Sep 2017 Compassionate Release Policy Reform: Physicians as Advocates for Human Dignity Andreas Mitchell and Brie Williams, MD, MS Compassionate release policies offering early release or parole to seriously ill incarcerated patients are underutilized and should be advocated for. AMA J Ethics. 2017;19(9):854-861. doi: 10.1001/journalofethics.2017.19.9.peer2-1709.
Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708.
Case and Commentary Jan 2005 Physician Activism: Doctors Go on Strike Karine Morin, LLM Virtual Mentor. 2005;7(1):121-124. doi: 10.1001/virtualmentor.2005.7.1.ccas21-0501.
Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611.
Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611.